Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04002583 · ClinicalTrials.gov registry record · NA
48-hour Ambulatory EEG Monitoring in Early Onset Alzheimer's Disease
A NA study of Early Onset Alzheimer Disease, sponsored by Mayo Clinic.
- Active
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT04002583: Active NA study of Early Onset Alzheimer Disease, sponsored by Mayo Clinic.
NCT04002583 is a NA study of Early Onset Alzheimer Disease that is active but no longer recruiting, run by Mayo Clinic. The registered enrollment target is 20 participants, below the 637-participant average among 3 other Early Onset Alzheimer Disease trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04002583, a NA study of Early Onset Alzheimer Disease, is active but no longer recruiting, sponsored by Mayo Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Researchers are trying to determine the frequency of seizures and epilepsy in patients with Early-onset Alzheimer's disease (EOAD) using a 48-hour computer assisted ambulatory electroencephalogram.
Primary Outcome
Number of subjects with electrographic seizures in 48 hours on computer assisted ambulatory EEG
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Computer assisted ambulatory electroencephalogram
Study Locations (1)
Florida
- Mayo Clinic in Florida - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2020-02-19 |
| Est. Completion | 2026-12 |
| Phase | NA |
What the registry record for NCT04002583 still lists
NCT04002583 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 637-participant average among 3 other Early Onset Alzheimer Disease trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Early Onset Alzheimer Disease appearing as the primary indexed condition, and to 1 intervention - of which Computer assisted ambulatory electroencephalogram is the first listed.
NCT04002583 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT04002583 about?
NCT04002583 is a clinical study titled "48-hour Ambulatory EEG Monitoring in Early Onset Alzheimer's Disease". Researchers are trying to determine the frequency of seizures and epilepsy in patients with Early-onset Alzheimer's disease (EOAD) using a 48-hour computer assisted ambulatory electroencephalogram.
What is the current status of trial NCT04002583?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2020-02-19. Estimated completion is 2026-12.
What conditions does trial NCT04002583 study?
This clinical trial studies the following conditions: Early Onset Alzheimer Disease.
What interventions are being tested in trial NCT04002583?
The interventions under investigation include: Computer assisted ambulatory electroencephalogram (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04002583?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04002583 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Early Onset Alzheimer Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI